HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3 Corrigendum in /10.3892/ijo.2022.5403

Han,Tao; Yan,Jun; Chen,Haini; Ji,Yi; Chen,Jianbing; Cui,Jie; Shen,Weimin; Zou,Jijun

doi:10.3892/ijo.2018.4623

HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3

Corrigendum in: /10.3892/ijo.2022.5403

Authors:
- Tao Han
- Jun Yan
- Haini Chen
- Yi Ji
- Jianbing Chen
- Jie Cui
- Weimin Shen
- Jijun Zou
View Affiliations

Affiliations: Department of Burns and Plastic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China
Published online on: November 5, 2018 https://doi.org/10.3892/ijo.2018.4623
Pages: 139-151
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia‑inducible factor‑1α (HIF‑1α) is upregulated in various tumors and associated with lymphangiogenesis and angiogenesis during tumor development and metastasis. However, the role of HIF‑1α in cystic lymphatic malformations (cLM) remains unclear. In the present study, expression of HIF‑1α and vascular endothelial growth factor receptor 3 (VEGFR‑3) was evaluated in 20 pairs of cLM specimens from patients who accepted curative surgery at Children's Hospital of Nanjing Medical University (Nanjing, China). Additionally, a stable HIF‑1α‑overexpressing human lymphatic endothelial cell (HLEC) line was established. Overexpression and silencing of HIF‑1α were used to investigate the biological role in colony formation, migration and lymphatic tube formation. HIF‑1α and VEGFR‑3 were upregulated in cLM specimens compared with adjacent normal tissues. In addition, HIF‑1α effectively induced HLEC colony formation and migration. Furthermore, lymphatic malformation of HLECs was promoted in vitro by overexpression of HIF‑1α. HIF‑1α overexpression upregulated VEGFR‑3 during lymphangiogenesis. Additionally, expression of lymphatic endothelial markers prospero homeobox protein 1 and lymphatic vessel endothelial hyaluronan receptor 1 increased significantly during lymphatic tube malformation. The presented data demonstrated that HIF‑1α overexpression in HLECs promoted colony formation, migration and tube malformation via upregulation of VEGFR‑3. These findings may assist in the development of HIF‑1α‑targeted cLM therapeutics in the future.

View Figures

View References

1	Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, et al ISSVA Board and Scientific Committee: Vascular anomalies classification: Recommendations from the International Society for the study of vascular anomalies. Pediatrics. 136:e203–e214. 2015. View Article : Google Scholar : PubMed/NCBI
2	Florez-Vargas A, Vargas SO, Debelenko LV, Perez-Atayde AR, Archibald T, Kozakewich HP and Zurakowski D: Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations. Lymphology. 41:103–110. 2008.PubMed/NCBI
3	Defnet AM, Bagrodia N, Hernandez SL, Gwilliam N and Kandel JJ: Pediatric lymphatic malformations: Evolving understanding and therapeutic options. Pediatr Surg Int. 32:425–433. 2016. View Article : Google Scholar : PubMed/NCBI
4	Mulliken JB, Burrows PE and Fishman SJ: Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd edition. Oxford University Press; Oxford; 2013, View Article : Google Scholar
5	Fonkalsrud EW: Lymphatic disorders. Pediatric surgery. Grosfeld JL: Mosby/Elsevier; Philadelphia, PA: pp. 2137–2146. 2006, View Article : Google Scholar
6	Sun ZJ, Zhang L, Zhang WF, Liu B, Li ZB and Zhao YF: A possible hypoxia-induced endothelial proliferation in the pathogenesis of epithelioid hemangioma. Med Hypotheses. 67:1133–1135. 2006. View Article : Google Scholar : PubMed/NCBI
7	North PE, Waner M, Mizeracki A and Mihm MC Jr: GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 31:11–22. 2000. View Article : Google Scholar : PubMed/NCBI
8	Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, et al: RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 34:1632–1641. 2013. View Article : Google Scholar : PubMed/NCBI
9	Liao D and Johnson RS: Hypoxia: A key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
10	Fulda S and Debatin KM: HIF-1-regulated glucose metabolism: A key to apoptosis resistance? Cell Cycle. 6:790–792. 2007. View Article : Google Scholar : PubMed/NCBI
11	Simon F, Bockhorn M, Praha C, Baba HA, Broelsch CE, Frilling A and Weber F: Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue - influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg. 395:395–405. 2010. View Article : Google Scholar : PubMed/NCBI
12	Tao J, Li T, Li K, Xiong J, Yang Z, Wu H and Wang C: Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer. J Huazhong Univ Sci Technolog Med Sci. 26:562–564. 2006. View Article : Google Scholar
13	Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T and Naito Z: Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol. 78:123–130. 2005. View Article : Google Scholar : PubMed/NCBI
14	Secker GA and Harvey NL: VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels. Dev Dyn. 244:323–331. 2015. View Article : Google Scholar
15	Tammela T, Saaristo A, Lohela M, Morisada T, Tornberg J, Norrmén C, Oike Y, Pajusola K, Thurston G, Suda T, et al: Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood. 105:4642–4648. 2005. View Article : Google Scholar : PubMed/NCBI
16	Liang X, Yang D, Hu J, Hao X, Gao J and Mao Z: Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. Anticancer Res. 28(3A): 1659–1666. 2008.PubMed/NCBI
17	Mizukami Y, Li J, Zhang X, Zimmer MA, Iliopoulos O and Chung DC: Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res. 64:1765–1772. 2004. View Article : Google Scholar : PubMed/NCBI
18	Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S and Maitre B: Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol. 279:L371–L378. 2000. View Article : Google Scholar : PubMed/NCBI
19	Shen W, Weiping S, Cui J, Chen J and Zou J: Management of cystic lymphangioma in the head and neck region: Endoscopic cautery and postoperative intratumoral negative pressure. J Craniofac Surg. 21:1884–1886. 2010. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Perkins JA: New frontiers in our understanding of lymphatic malformations of the head and neck: Natural history and basic research. Otolaryngol Clin North Am. 51:147–158. 2018. View Article : Google Scholar
22	Ji RC: Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Lett. 346:6–16. 2014. View Article : Google Scholar
23	Chen S, Zhang M, Xing L, Wang Y, Xiao Y and Wu Y: HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling. PLoS One. 10:e01211152015. View Article : Google Scholar
24	Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, Bucana CD, Semenza GL and Ellis LM: Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst. 96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
25	Nam SY, Ko YS, Jung J, Yoon J, Kim YH, Choi YJ, Park JW, Chang MS, Kim WH and Lee BL: A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis. Br J Cancer. 104:166–174. 2011. View Article : Google Scholar
26	Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, Toge T and Chayama K: Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer. 40:1904–1912. 2004. View Article : Google Scholar : PubMed/NCBI
27	Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R and Birner P: Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat. 99:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
28	Zhu H and Zhang S: Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. J Cell Biochem. 119:7707–7718. 2018. View Article : Google Scholar : PubMed/NCBI
29	Morfoisse F, Kuchnio A, Frainay C, Gomez-Brouchet A, Delisle MB, Marzi S, Helfer AC, Hantelys F, Pujol F, Guillermet-Guibert J, et al: Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism. Cell Reports. 6:155–167. 2014. View Article : Google Scholar
30	Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M and Chayama K: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 105:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
31	Koshikawa N, Iyozumi A, Gassmann M and Takenaga K: Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene. 22:6717–6724. 2003. View Article : Google Scholar : PubMed/NCBI
32	Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI and Kirkpatrick CJ: Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. Int J Oncol. 32:585–592. 2008.PubMed/NCBI
33	Okada K, Osaki M, Araki K, Ishiguro K, Ito H and Ohgi S: Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res. 25:3003–3009. 2005.PubMed/NCBI
34	Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W and Fan YZ: Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin. Int J Oncol. 41:1762–1772. 2012. View Article : Google Scholar : PubMed/NCBI
35	Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC and Kuo ML: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 96:541–545. 2007. View Article : Google Scholar
36	Teng X, Li D and Johns RA: Hypoxia up-regulates mouse vascular endothelial growth factor D promoter activity in rat pulmonary microvascular smooth-muscle cells. Chest. 121(Suppl): 82S–83S. 2002. View Article : Google Scholar : PubMed/NCBI
37	O TM and Lou MS: Zinc effect on human lymphatic malformation cells in vitro. Int J Pediatr Otorhinolaryngol. 80:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
38	Boscolo E, Coma S, Luks VL, Greene AK, Klagsbrun M, Warman ML and Bischoff J: AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 18:151–162. 2015. View Article : Google Scholar :
39	Semenza GL: HIF-1 mediates metabolic responses to intra-tumoral hypoxia and oncogenic mutations. J Clin Invest. 123:3664–3671. 2013. View Article : Google Scholar : PubMed/NCBI
40	Hong SS, Lee H and Kim KW: HIF-1alpha: A valid therapeutic target for tumor therapy. Cancer Res Treat. 36:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
41	Oliveira SL, Trujillo CA, Negraes PD and Ulrich H: Effects of ATP and NGF on Proliferation and Migration of Neural Precursor Cells. Neurochem Res. 40:1849–1857. 2015. View Article : Google Scholar : PubMed/NCBI
42	Chen JB, Liu WJ, Che H, Liu J, Sun HY and Li GR: Adenosine-5′-triphosphate up-regulates proliferation of human cardiac fibroblasts. Br J Pharmacol. 166:1140–1150. 2012. View Article : Google Scholar : PubMed/NCBI
43	Song X, Rui C, Meng L, Zhang R, Shen R, Ding H, Li J, Li J and Long W: Long non-coding RNA RPAIN regulates the invasion and apoptosis of trophoblast cell lines via complement protein C1q. Oncotarget. 8:7637–7646. 2017.
44	Xia H, Li Y and Lv X: MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int J Oncol. 49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
45	Xie F, Huang Q, Liu CH, Lin XS, Liu Z, Liu LL, Huang DW and Zhou HC: MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer. Eur Rev Med Pharmacol Sci. 22:678–686. 2018.PubMed/NCBI
46	Wang J, Yang S, Ge W, Wang Y, Han C and Li M: MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1. J Cell Biochem. 119:5118–5125. 2018. View Article : Google Scholar
47	Dai J, Wang J, Yang L, Xiao Y and Ruan Q: miR-125a regulates angiogenesis of gastric cancer by targeting vascular endothelial growth factor A. Int J Oncol. 47:1801–1810. 2015. View Article : Google Scholar : PubMed/NCBI